{
  "name" : "zero.sci-hub.se_5173_277b625cf382d590bcdc55293817e963_li2016.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Oxidative stress-mediated selective antimicrobial ability of nano- VO2 against Gram-positive bacteria for environmental and biomedical applications",
    "authors" : [ "Jinhua Li", "Huaijuan Zhou", "Jiaxing Wang", "Donghui Wang", "Ruxiang Shen", "Xianlong Zhang", "Ping Jina", "Xuanyong Liua" ],
    "emails" : [ ],
    "sections" : [ {
      "heading" : null,
      "text" : "This is an Accepted Manuscript, which has been through the Royal Society of Chemistry peer review process and has been accepted for publication.\nAccepted Manuscripts are published online shortly after acceptance, before technical editing, formatting and proof reading. Using this free service, authors can make their results available to the community, in citable form, before we publish the edited article. We will replace this Accepted Manuscript with the edited and formatted Advance Article as soon as it is available.\nYou can find more information about Accepted Manuscripts in the Information for Authors.\nPlease note that technical editing may introduce minor changes to the text and/or graphics, which may alter content. The journal’s standard Terms & Conditions and the Ethical guidelines still apply. In no event shall the Royal Society of Chemistry be held responsible for any errors or omissions in this Accepted Manuscript or any consequences arising from the use of any information it contains.\nAccepted Manuscript\nNanoscale\nwww.rsc.org/nanoscale\nView Article Online View Journal\nThis article can be cited before page numbers have been issued, to do this please use: J. Li, H. Zhou, J.\nWang, D. Wang, R. Shen, X. Zhang, P. Jin and X. Liu, Nanoscale, 2016, DOI: 10.1039/C6NR02844F.\nNanoscale\nARTICLE\nThis journal is © The Royal Society of Chemistry 2016 Nanoscale, 2016,XX, X-X | X\nReceived 00th January 20xx, Accepted 00th January 20xx\nDOI: 10.1039/x0xx00000x\nwww.rsc.org/\nOxidative stress-mediated selective antimicrobial ability of nanoVO2 against Gram-positive bacteria for environmental and biomedical applications\nJinhua Li,a, b Huaijuan Zhou,a, b Jiaxing Wang,c Donghui Wang,a,b Ruxiang Shen,a Xianlong Zhang,c Ping Jina, d, * and Xuanyong Liua, *\nVanadium dioxide (VO2) is a unique thermochromic material contributed by its semiconductor-metal transition, holding\ngreat promise for energy-saving intelligent windows. Herein, pure nano-VO2 from discrete nanoparticles to continuous films\nwere successfully deposited on quartz glass by controlling sputter parameters. It further demonstrated that, for Gram-\npositive S. aureus and S. epidermidis, the nano-VO2 could effectively disrupt bacteria morphology and membrane integrity,\nand eventually cause death. By contrast, the nano-VO2 did not exert significant toxicity on Gram-negative E. coli and P.\naeruginosa. To our knowledge, this is the first time to report on a selective antimicrobial effect of nano-VO2 materials on\nGram-positive bacteria. Based on the experimental results, a plausible mechanism was proposed for the antimicrobial\nselectivity, which might originate from the different sensitivity of Gram-positive and Gram-negative bacteria to intracellular\nreactive oxygen species (ROS) level. Elevated intracellular ROS level exceed the threshold that bacteria can self-regulate to\nmaintain cellular redox homeostasis and thus cause oxidative stress, which can be alleviated by elaborate intervention of\nglutathione (GSH) antioxidant. In addition, nano-VO2 did not produce significant cytotoxicity (hemolysis) against human\nerythrocytes within 12 h. Meanwhile, potential cytotoxicity against HIBEpiC revealed a time and dose dependent manner\nthat might be controlled and balanced by elaborate design. The finding in the present work may contribute to understanding\nthe antimicrobial behaviors of nano-VO2 and expanding the new applications of VO2-based nanomaterials in environmental\nand biomedical fields."
    }, {
      "heading" : "1. Introduction",
      "text" : "Smart windows, capable of regulating solar/heat transmittance for energy efficiency and comfort, have the potential to moderate the energy consumptions of buildings, which is almost the equivalent of 30~40% of the primary energy used in the worldwide. Vanadium dioxide (VO2) has been regarded as the promising material for thermochromic intelligent windows owing to its unique semiconductor-metal transition (SMT) temperature near room temperature. During the cold days when the extraventricular temperature is below the SMT temperature, VO2 has a monoclinic structure (P21/c) and is infrared-transparent to keep the warmth of inside house and maintains visible transmittance. On the contrary, during hot days, VO2 transforms to high-temperature rutile structure (P42/mnm) which is infrared-reflective to ensure that less infrared light is passed into the house.1 On the one hand, when VO2 is utilized as surface coating of windows in buildings or cars, it is exposed to surrounding environment and inevitably touched by human bodies,\nespecially by hands. On the other hand, detrimental environmental microbes exist everywhere around, such as in air, water, food and so forth.2 In this case, the pathogens adhering on surface will cause potential health threats to individuals and public. In this context, if VO2-based smart window has the ability to kill some bacteria, it will be of great significance and necessity for VO2 in practical application.\nFrom the perspective of biomedical purpose, nowadays, antibiotic-resistant bacteria create huge needs for breakthrough in treating infectious diseases.3-5 The situation of antimicrobial resistance is so serious. For example, vancomycin-resistant Enterococcus (VRE) has an intrinsic resistance to some commonly used antibiotics, as well as developing resistance to all currently available antibiotics.5 Methicillin-resistant S. aureus (MRSA) accounts for more than 40% of S. aureus strains in hospitals,4 and vancomycinresistant S. aureus (VRSA) is a global and daunting medical challenge because vancomycin is the most effective treatment for S. aureus infection.6-7 Meanwhile, multi-drug resistance has also been increasing among Gram-negative bacteria.5, 8 In the context of research and clinical applications, it is very impending today to develop novel and effective antimicrobial drugs. Nanomaterialbased antimicrobial agents provide a new paradigm for overcoming antibiotics-resistant pathogens, which has been explored as a promising alternative to current antibiotics-based methods.9-12 Meanwhile, they also hold great promise for applications in environmental system where biofouling is a major cause of elevated operation costs in marine transport, membrane-based water treatment and heat exchangers.13-15 Some engineered oxide nanoparticles have shown excellent antimicrobial property, such as a. State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai 200050, China. b. University of Chinese Academy of Sciences, Beijing 100049, China. c. Department of Orthopaedics, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai Jiao Tong University, Shanghai 200233, China. d. Materials Research Institute for Sustainable Development, National Institute of Advanced Industrial Science and Technology, Nagoya 463-8560, Japan.\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n1 2\nM ay\n2 01\n6. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa nt\na B\nar ba\nra o\nn 14\n/0 5/\n20 16\n1 6:\n56 :1\n3.\nView Article Online DOI: 10.1039/C6NR02844F\nX | Nanoscale, 2016,XX, X-X This journal is © The Royal Society of Chemistry 2016\nZnO,16 CuO,17 TiO2,18 Mn2O3 and Ni2O3,10 etc. This motivates us to explore the antimicrobial potential of nano-VO2 materials. As far as we know, the antimicrobial studies of VO2-based nanomaterials have not yet been previously reported.\nThat determines the toxicity of vanadium is its physicochemical states, especially its solubility and valence state.19-20 Vanadium owns six oxidation states, with trivalence(+3), tetravalence(+4), and pentavalence(+5) as the most common forms in nature. The increase in oxidation state will elevate the toxicity of vanadium.21-22 On the one hand, among various subcellular organelle, mitochondrion, the powerhouse of the cell, is a momentous target for vanadium accumulation and cytotoxicity in biological systems.23-25 On the other hand, based on the Endosymbiotic theory (Symbiogenesis), eukaryote mitochondria are an analogue of prokaryote bacteria. In this context, it is expected that vanadium may also impose toxic effect on bacteria just as it does on mitochondria, in other words, have antimicrobial potential.\nIn fact, some vanadium coordination organic compounds have shown the potential for treating epidemic diseases caused by parasites.26-28 Vanadium-substituted polyoxidotungstate, decomposing into active species vanadate(+5) and tungstate(+4) at physiological conditions, also shows in vitro antiviral activity against viruses causing influenza and Dengue fever, human immune deficiency virus (HIV-1) and severe acute respiratory syndrome (SARS).29-30 More excitingly, V(+5) complex [VO2(tsc)] and its V(+4) precursor [VO(acac)tsc] (tsc, thiosemicarbazone; acac, acetylacetonate) show inhibiting effect on tuberculosis pathogens, Mycobacterium tuberculosis.31 All these signs point out that it is quite worth trying to explore the antimicrobial potential of nano-VO2.\nWe deduce that VO2 may possess the capacity of killing bacteria. If so, it will be of great significance for both environmental and biomedical applications. To explore the conjecture above, the antibacterial potentials of nano-VO2 (from particle to film) on typical representatives of Gram-positive bacteria (Staphylococcus aureus and Staphylococcus epidermidis) and Gram-negative bacteria (Escherichia coli and Pseudomonas aeruginosa) were investigated in this work. Human erythrocytes and intrahepatic biliary epithelial cells were used to evaluate the potential cytotoxicity. The prepared nano-VO2 showed a selective antimicrobial effect on the Grampositive bacteria and a plausible mechanism behind the antibacterial selectivity was proposed from the perspective of difference in susceptibility to intracellular reactive oxygen species (ROS) level. To our knowledge, this is the first time to report on the selective antimicrobial property of nano-VO2, and the finding may be conducive to understanding the antibacterial behaviors of nano-VO2 and designing the new applications of VO2-based nanomaterials for environmental and biomedical purposes."
    }, {
      "heading" : "2. Materials and experimental methods",
      "text" : ""
    }, {
      "heading" : "2.1 VO2 deposition and sample preparation",
      "text" : "The high quality VO2 from discrete nanoparticles to continuous films were prepared by magnetron sputtering apparatus (ULVAC Corp.,\nModel ACS-4000-C4) with metal vanadium target. Fused quartz was\nused as the substrate for VO2 deposition. The process parameters for VO2 deposition can be found in our previous work.32-33 To obtain the VO2 samples from discrete nanoparticles to continuous films, VO2 was deposited on quartz substrate within 10 min, followed by\nvacuum annealing treatment at 450 ºC. For simplicity, the VO2 samples from discrete nanoparticles to continuous films on quartz\ndeposited for 2 min, 4 min, 6 min and 8 min were denoted as VO-1,\nVO-2, VO-3 and VO-4, respectively. Meanwhile, the quartz glass\nacted as the control group (VO-0)."
    }, {
      "heading" : "2.2. Sample surface characterization",
      "text" : "A field-emission scanning electron microscope (FE-SEM; HITACHI S-4800, Japan) was used to examine the surface morphology of samples VO-0, VO-1, VO-2, VO-3 and VO-4. An X-ray photoelectron spectroscopy (XPS; PHI 5802, Physical Electronics Inc, Eden Prairie, MN) with an Al Kα (1486.6 eV) source was used to investigate the surface chemical components and element chemical states of samples VO-1, VO-2, VO-3 and VO-4."
    }, {
      "heading" : "2.3. Zeta potential measurement",
      "text" : "A SurPASS Electrokinetic Analyzer (EKA; Anton Paar GmbH, Graz, Austria), equipped with a special cell for film/membrane samples, was adopted to measure the zeta potentials (ζ) of specimens VO-0, VO-1, VO-2, VO-3 and VO-4 surfaces in sizes of 20 mm × 10 mm × 1 mm. The testing samples were fixed on holders with double-sided adhesive tape. The electrolyte of 0.9 wt% NaCl saline solution served as the measuring medium; the HCl and NaOH solutions were added to regulate the medium’s pH. For the streaming potential measurement, the electrolyte was pumped to flow along a pair of specimen surfaces and the potentials originating from the ions’ motion in diffusion layer were recorded according to the HelmholtzSmoluchowski equation,\n0\n \n     \ndU K dP\nNote: ζ, zeta potential; dU/dP, slope of streaming potential versus pressure; η, electrolyte viscosity; ε0, vacuum permittivity; ε, dielectric constant of electrolyte; K, conductivity. These parameters were collected and finally gave the ζ potential values from SurPASS control and evaluation software automatically."
    }, {
      "heading" : "2.4. Vanadium release measurement",
      "text" : "The release profiles of vanadium ions from the surfaces of samples VO-0, VO-1, VO-2, VO-3 and VO-4 in agar-free Trypticase Soy Broth (TSB) medium, agar-free Luria-Bertani (LB) medium and phosphate buffered saline (PBS, pH 6.8/7.4, adjusted by HCl solution) were measured by an inductively coupled plasma optical emission spectrometry (ICP-OES, Varian Liberty 150, US). These samples were soaked in 10 ml fresh medium in 15 ml sterile microcentrifuge tubes, followed by successive incubation at 37 °C for 1, 4, 7 and 14 days in static condition. At each end of the desired incubation period, the leachates were collected for ICP-OES measurements and the tubes were supplemented with fresh medium for subsequent incubation."
    }, {
      "heading" : "2.5. Antibacterial potential assessment",
      "text" : "In the present work, Gram-positive Staphylococcus aureus (S. aureus, ATCC 25923, biofilm-positive) and Staphylococcus epidermidis (S. epidermidis, ATCC 35984, biofilm-positive), and Gram-negative Escherichia coli (E. coli, ATCC 25922, biofilm-positive) and Pseudomonas aeruginosa (P. aeruginosa, ATCC 27853, biofilmpositive) were utilized to evaluate the antibacterial potential of samples VO-0, VO-1, VO-2, VO-3 and VO-4.\nThe antimicrobial potential was investigated by the AlamarBlue assay. S. aureus and S. epidermidis were cultured in tryptic soy broth (TSB) media, and E. coli and P. aeruginosa were cultured in Luria– Bertani (LB) media. After sterilizing the samples VO-0, VO-1, VO-2, VO-3 and VO-4 in ethanol solution (75 v/v%) and drying on super\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n1 2\nM ay\n2 01\n6. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa nt\na B\nar ba\nra o\nn 14\n/0 5/\n20 16\n1 6:\n56 :1\n3.\nView Article Online DOI: 10.1039/C6NR02844F\nThis journal is © The Royal Society of Chemistry 2016 Nanoscale, 2016,XX, X-X | X\nclean bench, a droplet of bacterial solution (60 μl, 107 CFU/ml) was inoculated onto each specimen surface in 24-well plate (1×1 cm2, five specimens per group). After subsequent incubation at 37 ºC for 24 h in the dark, the AlamarBlue assay was performed to estimate the bacterial viability and antimicrobial potential. Briefly, 500 μl fresh medium with 10 v/v% AlamarBlue was added into each well, followed by incubation for 4 h in the dark. Then 100 μl medium was transferred into 96-well plate for measuring and calculating the accumulation of reduced AlamarBlue in medium on Cytation 5 Cell Imaging Multi-Mode Reader (BioTek, US) at 570 nm and 600 nm according to the following formula,\n1 2\n1 Re 2\n117, 216 80, 586 100%\n155, 677 14, 652\n \n \n    \n   \nA A AlamarBlue\nA A\nNote: A, the absorbance of test wells; A', the absorbance of negative control wells (with medium plus AlamarBlue but no bacteria); λ1 = 570 nm and λ2 = 600 nm.\nHere, the bacterial viability was defined as follow:\nRe\nRe\n% Bacterial Viability 100% '\n  AlamarBlue\nAlamarBlue\nNote: AlamarBlueRe, reduction rate of AlamarBlue in test wells (VO1, VO-2, VO-3, VO-4 groups); AlamarBlueRe', reduction rate of AlamarBlue in positive control wells (VO-0 group).\nThen SEM observation was performed to examine the bacterial morphology and membrane integrity, as indicator of bacterial viability. After 24 h of culture as above, the bacteria on samples were fixed in 2.5% glutaraldehyde solution for overnight at 4 ºC, then sequentially dehydrated in 30, 50, 75, 90, 95 and 100 v/v% ethanol solutions for 10 min, with final dehydration in absolute ethanol (twice) and drying in hexamethyldisilizane (HMDS) ethanol solution.\nTo visualize the bacterial viability and membrane integrity, LIVE/DEAD® BacLight™ Kit (L13152, Molecular Probes) was utilized to stain the bacteria in situ on various samples at room temperature for 15 min in the dark. Propidium iodide (PI, red fluorescent dye for dead bacteria) and SYTO 9 (green fluorescent dye for live bacteria) were mixed before use according to the manufacturer’s instruction. Then they were observed on a confocal laser scanning microscopy (CLSM, Leica SP8, Germany)."
    }, {
      "heading" : "2.6. Hydrogen peroxide study",
      "text" : "To investigate the behavior responses of Gram-positive bacteria (S. aureus and S. epidermidis) and Gram-negative bacteria (E. coli and P. aeruginosa) toward hydrogen peroxide (H2O2), the H2O2 concentration dependent microbial viability was studied by AlamarBlue assay to plot the growth-inhibitory curves of these microbes in H2O2-containing medium. And the half maximal inhibitory concentration (IC50) values were obtained by GraphPad Prism 5 statistical software package. In brief, before use, H2O2 (AR, 30%) solution was freshly diluted in PBS to 10 M stock solution, filtration sterilized, and then diluted in PBS to prepare working solution with concentrations ranging from 10 M to 0. After that, the bacterial solution (107 CFU/ml) were inoculated into 96-well plate pre-supplemented with the above working solution. After 24 h of culture, the AlamarBlue assay was performed to measure the bacterial viability as above. The test was repeated five times independently under the same experimental conditions, strictly following the manufacturer's instructions. The final IC50 values were expressed as means ± standard deviation. 2.7. Intracellular ROS assay\nIntracellular ROS levels in the bacterial cells were determined by Intracellular ROS Assay Kit (Beyotime, China) following the manufacturer’s instruction.34 In this assay, 2’,7’- dichlorodihydrofluorescein diacetate (DCFH-DA) can pass through bacterial membrane and be deacetylated by intracellular esterases into non-fluorescent dichlorofluorescin (DCFH) to stay in bacteria, which can be oxidized into highly fluorescent 2’,7’- dichlorofluorescein (DCF) by intracellular ROS.35 After 24 h of culture as above, bacteria were thoroughly detached from sample surface by vigorously vibrating in vortex mixer. Aliquots of 100 μl were taken from each specimen to determine the number of bacteria, and remanent bacterial suspensions were collected into 96-well flatbottom black plate to measure the relative fluorescent intensity (RFI) of intracellular ROS. Briefly, DCFH-DA (10 μM) was added into the above bacterial suspensions in 96-well black plate, followed by 20 min of incubation at 37 ºC. Then the RFI was detected on Cytation 5 Cell Imaging Multi-Mode Reader (BioTek, US) at excitation wavelength λex=485 nm and emission wavelength λem=535 nm. Here, the intracellular ROS level was defined as follow,36 which was then normalized to that of the control group VO-0 to obtain the fold increase.\nIntracellular RFI Intracellular ROS level\nbacterial number "
    }, {
      "heading" : "2.8. Antioxidant incubation study",
      "text" : "To explore the potential role of oxidative stress in nano-VO2 induced bacterial inactivation, we co-incubated the Gram-positive bacteria (S. aureus and S. epidermidis) with 10 mM glutathione (reduced form, GSH), the major endogenous antioxidant, to alleviate/remove the contribution of oxidative stress in the bacterial response to the nano-VO2 exposure. This strategy has been previously revealed to effectively attenuate the oxidative stress induced by cellular pro-oxidants.37-38 The bacterial viability and intracellular ROS level were evaluated by using the methods as described above. At the same time, the LIVE/DEAD® BacLight™ Kit (L13152, Molecular Probes) was used to stain the co-incubated bacteria to visualize their bacterial viability and membrane integrity (Please see details in Section 2.5)."
    }, {
      "heading" : "2.9. CFU counting assay",
      "text" : "To further corroborate the above AlamarBlue assay results, the CFU counting assay was carried out on the Gram-positive bacteria (S. aureus and S. epidermidis) with/without GSH co-incubation. After sterilizing the samples in ethanol solution (75 v/v%) and drying them on super clean bench, a droplet of bacterial solution (60 μl, 107 CFU/ml) with/without 10 mM GSH was inoculated onto each sample surface (1×1 cm2) in a 24-well plate, followed by another 24 h of incubation at 37 ºC in the dark. Afterwards, the CFU counting assay was conducted. In brief, each sample with bacterial solution was gently transferred into 1 ml of sterile PBS, followed by 10 min of ultrasonic vibration (150 W, B3500S-MT, Branson Ultrasonics Co., Shanghai, China) and 1 min of rapid vortex mixing (Vortex Genie 2, Scientific Industries, Bohemia, NY, USA) to dissociate the bacteria thoroughly. The bacterial suspension was then taken out and the viable counts of bacteria were measured by serial dilution and spread-plate method.39 The numbers of CFU on the sheep blood agar (SBA) were counted according to the National Standard of China GB/T 4789.2 protocol. Each test was repeated thrice. The antibacterial rate was calculated by the following formula,\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n1 2\nM ay\n2 01\n6. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa nt\na B\nar ba\nra o\nn 14\n/0 5/\n20 16\n1 6:\n56 :1\n3.\nView Article Online DOI: 10.1039/C6NR02844F\nX | Nanoscale, 2016,XX, X-X This journal is © The Royal Society of Chemistry 2016\n( ) (%) 100%   \na\nA B R\nA\nNote: A, average number of viable bacteria on VO-0 control; B, average number of viable bacteria on nano-VO2 samples."
    }, {
      "heading" : "2.10. Hemolysis assay",
      "text" : "Hemolysis assay was performed according to a modified method described elsewhere.40 Our experimental study was approved by Shanghai Jiao Tong University Affiliated Sixth People’s Hospital Ethics Committee (Ethical code, 2014-63). Human venous blood from healthy young volunteers was collected in tubes containing 10 μl of heparin. 10 ml of whole blood was centrifuged at 1200×g for 5 min, then the supernatant and buffy coat were gently removed and discarded. The red blood cells (RBC) were gently washed thrice with sterile PBS buffer solution (pH 7.4, Gibco). Subsequently, the RBC were resuspended in PBS solution at 2% hematocrit. After that, the RBC suspension was incubated with VO-0, VO-1, VO-2, VO-3, VO-4 (n = 3) and aseptic distilled water (positive control). Assay was incubated at 37 °C in an incubator for 15 min, 30 min, 60 min, 4 h and 12 h. At the end of each time period, one aliquot was withdrawn and intact RBC were removed by centrifugation at 1200×g for 5 min at 4 °C. The supernatants were collected and the hemolysis was analyzed by measuring the absorbance of hemoglobin at 540 nm. All measurements were taken in triplicate. The hemolysis rate was calculated as follow:\n'\nA Hemolysis rate 100%\nA  \nNote: A, absorbance of the testing samples; '\nA , absorbance of the positive control, indicating 100% of hemolysis extent."
    }, {
      "heading" : "2.11. Cell viability assessment",
      "text" : "To estimate the cytotoxicity of nano-VO2, the human intrahepatic biliary epithelial cells (HIBEpiC) were cultured on samples VO-0, VO-1, VO-2, VO-3 and VO-4. Briefly, HIBEpiC were seeded on these samples for 1, 4 and 7 d of culture in 24-well plate (density 5×104 cells/well, five samples per group) in Epithelial Cell Medium (EpiCM, ScienCell), supplemented with 10% FBS and 1% P/S. At the end of each culture period, the cellular medium was removed and AlamarBlue assay was performed to measure the cell proliferation and viability (Please see details in Section 2.5).\nWith the help of Live/Dead Cell Staining Kit (BioVision, US), CLSM was utilized to visualize the live and dead HIBEpiC. Briefly, HIBEpiC were firstly seeded on samples VO-0, VO-1, VO-2, VO-3 and VO-4 in 24-well plate (5×104 cells/well) for 4 d of culture. Then they were stained with the mixed solution of 5 μM PI (red fluorescent dye for dead cells) and 2 μM calcein-AM (green fluorescent dye for live cells) with 100 μl per well, followed by subsequent incubation for 15 min at 37 °C before CLSM observation."
    }, {
      "heading" : "2.12. Statistical analysis",
      "text" : "Statistically significant differences (P) between various groups were measured using one-way analysis of variance and Tukey’s multiple comparison tests on a GraphPad Prism 5 statistical software package. All the data were expressed as means ± standard deviation (SD). A value of P<0.05 was considered to be statistically significant and denoted as “*”, P<0.01 was “**”, and P<0.001 was “***”.\n3. Results and discussion 3.1. Sample characterization\nFigure 1. Surface morphology of samples VO-1 (a), VO-2 (b), VO-3 (c) and VO-4 (d) after VO2 deposition and vacuum annealing. Green arrows show the evolution of nano-VO2 from discrete nanoparticles to continuous film.\nTable 1. Elemental composition of various samples analyzed by XPS technique.\nSample\nElemental content (Atomic %)\nV Si O C\nVO-1 7.0 11.6 44.0 37.4\nVO-2 12.7 9.1 48.3 29.9\nVO-3 14.3 1.7 43.9 40.1\nVO-4 15.9 1.6 49.1 33.4\nFigure 1 shows the surface morphology evolution of VO2 samples after sputter depositing and vacuum annealing. For sample VO-1 (2 min), discrete VO2 nanoparticles were produced on quartz glass, as shown in Figure 1a (indicated by green arrow). Using XPS analysis technique, it can be seen that an evident XPS peak of V 2p emerged in Figure 2a. The content of V element on the surface was 7.0 at% for VO-1 (Table 1). Prolonging the time to 4 min, discrete VO2 nanoparticles began to interconnect with each other and formed discontinuous VO2 film morphology, as evidenced by the gaps on surface everywhere (Figure 1b, indicated with green arrow). The XPS peak of V 2p in Figure 2a showed significant intensity increase, consistent with the significantly elevated surface V content of 12.7% for sample VO-2. Up to 6 min for sample VO-3, the previous gaps of the discontinuous VO2 film began to coalesce together, leaving behind relatively continuous VO2 film topography, although some shallow gaps still can be found, as indicated in Figure 1c with green arrow. In this case, the surface V contents ascended to 14.3%, with relatively small increase. So, it can be inferred that, along with increasing the deposition time, the VO2 film tended to develop into continuous morphology on surface, accompanied by the smaller and smaller increase of surface V content since the sampling depth of XPS analysis technique is ~10 nm within the outermost surface. In this context, for sample VO-4 (8 min), the VO2 film has developed into completely continuous film morphology on quartz glass and no more gaps were left behind on surface, as seen in Figure 1d. Accordingly, the surface V content rose to 15.9% for sample VO-4.\nAs shown in Figure 2b, from the high resolution V 2p XPS spectra, it can be clearly seen that, the peak intensity gradually increased in a time-dependent manner, namely, as a function of deposition time. This was reflected by the accordant rising of surface V content. On the other hand, the valence state of V atoms in oxide was also demonstrated to be +4, since the XPS spectra included two peaks at 516.3 eV and 523.5 eV, which were attributed to the typical binding\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n1 2\nM ay\n2 01\n6. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa nt\na B\nar ba\nra o\nn 14\n/0 5/\n20 16\n1 6:\n56 :1\n3.\nView Article Online DOI: 10.1039/C6NR02844F\nThis journal is © The Royal Society of Chemistry 2016 Nanoscale, 2016,XX, X-X | X\nFigure 2. Surface analysis of chemical components and chemical states on samples VO-1, VO-2, VO-3 and VO-4, including the XPS full spectra (a) and the evolution of high resolution V 2p XPS peak (b) and Si 2p XPS peak (c), accompanied by the surface zeta potentials (ζ) of various samples (d).\nenergies for V 2p3/2 and V 2p1/2 in VO2, respectively.33 At the same time, it was also interesting that, from the high resolution Si 2p XPS spectra in Figure 2c, one can find that the evolution of Si 2p peak intensity showed a completely reverse trend with that of V 2p. And this was in accordance with the decrease of surface Si contents ranging from 11.6% of VO-1, 9.1% of VO-2, 1.7% of VO-3 to 1.6% of VO-4. As a result, this evolution of Si 2p peak provided another indirect and strong evidence to support the development of VO2 from discrete nanoparticles to continuous film when depositing on quartz glass.\nThe surface speciation and charge formation were also analysed for all specimens. The isoelectric point of surface (IEPS) is the pH of aqueous solution when total surface charge density is zero. A substrate surface is positively (negatively) charged when pH is lower (higher) than its IEPS. As shown in Figure 2d, for VO-0 (quartz), at IEPS (~3.7), the total charge density of the hydrated surface (SiO2+H2O=H2SiO3) was zero,41 and departure of pH from the IEPS altered the surface charge accordingly (H2SiO3+OH-→HSiO3-+H2O， pH ＞ 3.7 ； H2SiO3+H+→H3SiO3+ ， pH ＜ 3.7). For nano-VO2, at prevalent oxic conditions, intermediate state VO2 has a tendency to oxidize to V2O5 (4VO2+O2→2V2O5), and the total charge density of the hydrated surface (V2O5+3H2O=2H3VO4) at IEPS (<3) is zero.42 Here, above IEPS, a negatively charged surface was formed on nano-VO2 accordingly. For further analysis, the pKa values for vanadate were essential (H3VO4+H2O↔H2VO4-+H3O+ ， pKa=3.5 ； H2VO4+H2O↔HVO42-+H3O+ ， pKa=7.8 ； HVO42-+OH-↔VO43-+H2O ， pKa=12.5).43 As a result, negatively charged surface were formed on nanoVO2 in a wide pH range, as indicated in Figure 2d. From this figure, the difference and change in surface zeta potentials of quartz and nano-VO2 exactly reflected the evolution of the latter from discrete nanoparticles to continuous film. 3.2. Vanadium release\nFigure 3. Release profiles of vanadium ions after immersing in agar-free TSB (a), agar-free LB (b), PBS with pH 7.4 (c) and PBS with pH 6.8 (d) for 1, 4, 7, and 14 days.\nFigure 3 shows the release profiles of vanadium ions in different solutions within 14 d of immersion. From this figure, it can be seen that vanadium ions were slowly released from the surfaces of various VO2 samples in a time and dose dependent manner. On the other hand, the corresponding release rates and release amounts of vanadium ions showed no significant difference among various solutions, especially for agar-free TSB (Figure 3a) and agar-free LB (Figure 3b). The release of vanadium ions might correlate with its intracellular toxicity.44"
    }, {
      "heading" : "3.3. Selective antibacterial property",
      "text" : "To visualize the living state of bacteria, the bacterial morphology and membrane integrity were investigated by SEM technique. Randomly selecting an area at low magnification, as shown in Figure 4a1, large amounts of S. aureus were seen on quartz glass (VO-0), indicating they could grow well and form abundant biofilms on surface. Randomly selecting a domain to magnify (the inset), it can be seen that all the S. aureus were in regular spherical shape and size dimension; meanwhile, intact and smooth cytoplasmic membranes were protecting the bacteria. For VO-1 with discrete VO2 nanoparticles, at low magnification, the total number of S. aureus on surface had a significant decrease relative to that on VO0 (Figure 4a2). This indicated that the presence of VO2 nanoparticles could effectively inhibit the S. aureus growth on surface, although the bacterial morphology, size dimension and membrane integrity did not show apparent abnormal changes (the inset). For VO-2 with discontinuous film, at low magnification, the total count of S. aureus on surface were sharply reduced relative to that on VO-0 and VO-1 (Figure 4a3). Furthermore, bacterial size dimension fluctuated abnormally everywhere. Irregular bacterial morphology was observed at high magnification, accompanied by a rough appearance. Moreover, prevalent bacterial membrane damage and cytoplasm leakage came into view everywhere. Although some S. aureus still maintained membrane integrity, but they were out of shape, abnormally big or small, indicating their poor living state. This situation became more severe for VO-3 with discontinuous VO2 film (Figure 4a4). As for VO-4 with continuous VO2 film, randomly selecting a visual field, the total amount of S. aureus was quite few at low magnification (Figure 4a5), also accompanied by the abnormal bacterial size dimension, rough morphology, membrane disruption and cytoplasm leakage. The results showed that the nano-VO2 from discontinuous to continuous films could strongly combat the\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n1 2\nM ay\n2 01\n6. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa nt\na B\nar ba\nra o\nn 14\n/0 5/\n20 16\n1 6:\n56 :1\n3.\nView Article Online DOI: 10.1039/C6NR02844F\nX | Nanoscale, 2016,XX, X-X This journal is © The Royal Society of Chemistry 2016\nFigure 4. SEM observations on bacterial morphology and membrane integrity of S. aureus (ai), E. coli (bi), S. epidermidis (ci) and P. aeruginosa (di), where i = 1, 2, 3, 4, 5 represents samples VO-0, VO-1, VO-2, VO-3, and VO-4, respectively. Note: at low magnification, scale bar, 20 μm; the inset, scale bar, 2 μm.\nS.aureus proliferation on surface. Meanwhile, from Figure 4a2~a5, VO-2, VO-3 and VO-4 exhibited apparently stronger inhibition effect on S. aureus relative to VO-1. These bacterial morphology signs demonstrated the prepared nano-VO2 had good antibacterial effect on Gram-positive S. aureus even in the dark. On the contrary, for Gram-negative E. coli, as seen from the SEM results in Figure 4b1~b5, the total bacterial count, size dimension, bacterial morphology and membrane integrity did not have apparent differences among VO-0, VO-1, VO-2, VO-3 and VO-4. Besides, at low magnification, it is noted that E. coli tended to gather together. This will be further discussed. Thus, based on the SEM observations, it confirmed that the prepared nano-VO2 had no significant antibacterial effect on Gram-negative E. coli. We further utilized Gram-positive S. epidermidis and Gramnegative P. aeruginosa to verify the above SEM observations. For S. epidermidis, as shown in Figure 4c2~c5 at low magnification, the number of bacteria was significantly reduced on nano-VO2 relative to that on bare quartz (Figure 4c1). Meanwhile, at high magnification (the insets), the bacteria out of shape on nano-VO2 were prevalent, with leakage of cytoplasm. In contrast, for P. aeruginosa, the bacterial number at low magnification showed no significant difference and the insets showed compact bacteria contact and biofilm formation (Figure 4d1~d5). Besides, a more significant phenomenon of bacteria gathering was also observed for P. aeruginosa. In this case, it is natural to infer that the VO2-based nanomaterials seem to possess a selective antibacterial effect on Gram-positive S. aureus and S. epidermidis, rather than on Gramnegative E. coli and P. aeruginosa. To further demonstrate the above speculation, fluorescence live/dead staining was performed to visualize the bacterial membrane integrity and distinguish the live bacteria (stained in green) and dead bacteria (stained in red), so that to explore the antibacterial capability of VO2-based nanomaterials against the tested bacteria. For E. coli, as shown in Figure 5, there were no significant decrease in the green fluorescence for nano-VO2 relative to VO-0. Meanwhile, for all the samples, the red fluorescence were almost invisible and had no remarkable difference among them. Interestingly, the gathering phenomenon of E. coli was also observed by the staining method. For VO-2 with discontinuous VO2 film, the bacteria tended to gather together. This bacterial gathering\nFigure 5. Live/dead staining results of Gram-negative E. coli (left panel) and Grampositive S. aureus (right panel), visualizing the bacterial viability and membrane integrity after 24 h of culture on samples VO-0, VO-1, VO-2, VO-3, and VO-4.\nphenomenon became more and more obvious when the VO2 film developed from discontinuous to continuous, as evidenced by the staining results for VO-3 and VO-4, which was also observed in Figure 4b3-b5. According to the staining results for S. aureus, the strong green fluorescence on VO-0 indicated a large number of live bacteria with abundant biofilms; while the almost invisible red fluorescence showed few dead bacteria. However, a sharp contrast was formed after VO2 deposition. In detail, for VO-1 with discrete VO2 nanoparticles, the significantly decreased green fluorescence confirmed the sharply reduced viable bacteria count; meanwhile, it can be clearly seen that the red fluorescence had an obvious increase, demonstrating the severe disruption of membrane integrity and prevalent loss of bacterial viability. This situation is also true for VO2 and VO-3 with discontinuous VO2 films, especially for VO-4 with continuous VO2 film. To certify these observations, the staining method was further conducted on P. aeruginosa and S. epidermidis to obtain the fluorescence live/dead images, as shown in Figure 6. From this figure, the bacterial viability of P. aeruginosa was not impaired notably and its prevalent gathering phenomenon accorded well with the SEM observations (Figure 4d3~d5). On the contrast, it can be clearly seen that the nano-VO2 exerted significant antimicrobial effect on S. epidermidis. The gathering phenomenon may be some kind of stress response of E. coli and P. aeruginosa to the VO2 nanomaterials. The fluorescence staining results were quite consistent with the SEM results, together demonstrating that, the prepared nano-VO2 had selective antibacterial property against Gram-positive S. aureus and S. epidermidis, without apparent antimicrobial effect on Gram-negative E. coli and P. aeruginosa."
    }, {
      "heading" : "3.4. Plausible antibacterial mechanism",
      "text" : "The antibacterial potential of VO2-based nanomaterials should closely correlate with the vanadium toxicity that depends on its physicochemical states, especially on the valence states and solubility.19-20 Vanadium has six oxidation states and the most commonly found in nature are V(+3), V(+4), and V(+5). Vanadium toxicity ascends as the oxidation state increases.21-22 Our recent work showed that +5 valent vanadate (H2VO4−) anions were released from surface when immersing VO2 in PBS.45 The soluble H2VO4− are the main species at physiological pH since the pentavalent oxidation state is the most stable form among various oxidation states.25, 46\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n1 2\nM ay\n2 01\n6. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa nt\na B\nar ba\nra o\nn 14\n/0 5/\n20 16\n1 6:\n56 :1\n3.\nView Article Online DOI: 10.1039/C6NR02844F\nThis journal is © The Royal Society of Chemistry 2016 Nanoscale, 2016,XX, X-X | X\nFigure 6. Live/dead staining results of Gram-negative P. aeruginosa (left panel) and Gram-positive S. epidermidis (right panel), visualizing the bacterial viability and membrane integrity after 24 h of culture on samples VO-0, VO-1, VO-2, VO-3, and VO-4.\nFigure 7. (a-d) Bacterial viability and the corresponding intracellular ROS level of Gram-negative E. coli and P. aeruginosa; (e-h) Bacterial viability and the corresponding intracellular ROS level of Gram-positive S. aureus and S. epidermidis; (i) Illustration for structure and physiological function of glutathione (GSH); (j-m) Bacterial viability and the corresponding intracellular ROS level of S. aureus and S. epidermidis with coincubation with GSH antioxidant. The intracellular ROS level was obtained by normalizing the relative fluorescent intensity (RFI) of intracellular ROS to bacteria number, and then expressing the ROS fluorescence activity as fold increase relative to that of VO-0 control with relative value of 1. Note: *P<0.05, **P<0.01, ***P<0.001 vs VO-0; #P<0.05, ##P<0.01, ###P<0.001 vs VO-1; &P<0.05, &&&P<0.001 vs VO-2; NADPH, nicotinamide adenine dinucleotide phosphate.\nIn mammalian cells, H2VO4− is the most common intracellular form and can be actively transported into cells.47-50 Among subcellular organelle, mitochondria have been seen as a crucial target for vanadium accumulation and cytotoxicity.23-25 According to the Endosymbiotic theory, bacterium is analogous to mitochondrion of mammalian cell.51 On this basis, the observed antibacterial ability against Gram-positive S. aureus and S. epidermidis is proposed to originate from the vanadate uptake and accumulation in bacteria, which interferes with their normal physiological functions and causes the desired cytotoxicity against bacteria ultimately. Intracellular reducing conditions are known indicators of bacterial viability and death. When bacteria are alive, they maintain a reducing\nFigure 8. Representative photographs of recultivated bacteria colonies on SBA after culturing Gram-positive S. aureus and S. epidermidis on samples VO-0, VO-1, VO-2, VO-3 and VO-4 with/without adding GSH antioxidant for coincubation.\nenvironment within the cytosol. To detoxify the +5 valent vanadate (H2VO4−), bacteria will bioreduce the vanadate to +4 valent vanadyl (VO2+) through intracellualr reducing substances, for example, reduced glutathione (GSH).25, 47, 52 In this case, the bioreduction of H2VO4− to VO2+ begins with the redox couple as equation (1):\n2GSH↔GSSG + 2H+ + 2e- (1)\nwhere GSH and GSSG are the reduced and oxidized forms of glutathione, respectively.53-54 Secondly, the bioreduction reaction occurs as equation (2):47, 55\nH2VO4- + 4H+ + e- ↔ VO2+ + 3H2O (2) In fact, an in vitro study demonstrated that H2VO4− was completely reduced to VO2+ by GSH.56\nHerein, the bacteria seem to beat the rap, but it is not the case, as evidenced by the present work. So, there may exist some kind of further mechanism behind it. In fact, the VO2+ may induce the formation of reactive oxygen species (ROS), for example, the hydroxyl radical (●OH), in a Fenton-like reaction as equation (3):25, 57\nVO2+ + H2O2 + H+ → VO3+ + H2O + ●OH (3)\nOn the other hand, the VO2+ may also induce superoxide radical ( 2\n  O )\nby directly reacting with O2 as equation (4):58 VO2+ + O2 + 3H2O → H2VO4- + ●O2- + 4H+ (4)\nAs a consequence, it is postulated that the elevation of intracellular ROS may contribute to the observed antibacterial property of VO2based nanomaterials against Gram-positive S. aureus and S. epidermidis.2, 9, 35 In this context, the possible mechanism for the selective antibacterial activity was discussed here.\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n1 2\nM ay\n2 01\n6. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa nt\na B\nar ba\nra o\nn 14\n/0 5/\n20 16\n1 6:\n56 :1\n3.\nView Article Online DOI: 10.1039/C6NR02844F\nX | Nanoscale, 2016,XX, X-X This journal is © The Royal Society of Chemistry 2016\nFigure 9. Live/dead staining results of Gram-positive S. aureus (left panel) and S. epidermidis (right panel), visualizing the bacterial viability and membrane integrity after 24 h of culture with adding GSH antioxidant on samples VO-0, VO-1, VO-2, VO-3, and VO-4.\nFirstly, according to the bacterial viability results, the nano-VO2 did not show significant cytotoxicity against E. coli and P. aeruginosa (Figure 7a-b) relative to VO-0, which accorded well with the SEM and staining results. Accordingly, as shown in Figure 7c-d, after 24 h of culture, the intracellular ROS level of E. coli and P. aeruginosa showed no significant difference between nano-VO2 and quartz. On the contrary, the proliferation of S. aureus and S. epidermidis was significantly reduced on nano-VO2, as shown in Figure 7e-f. Consistent with the SEM and staining results, it also demonstrated the nano-VO2 had selective antibacterial property against the tested Gram-positive bacteria. Meanwhile, the intracellular ROS level of S. aureus and S. epidermidis showed several-fold increase than that on quartz. Upon the evolution of nano-VO2 from particle to film, the intracellular ROS level of S. aureus and S. epidermidis also indicated rhythmic varying pattern. At this point, it confirmed the elevated level of intracellular ROS should account for the selective antimicrobial effect of nano-VO2 on Gram-positive bacteria (S. aureus and S. epidermidis).\nTo further confirm the role of oxidative stress in nano-VO2 induced bacterial inactivation, we coincubated Gram-positive bacteria (S. aureus and S. epidermidis) with 10 mM GSH to eliminate the contribution of oxidative stress in the bacterial response to nanoVO2 exposure. GSH, a tripeptide of glutamate, glycine and cysteine residues (Figure 7i), is the major endogenous antioxidant, present at high levels (up to 10 mM) in bacteria.59 GSH scavenges ROS by donating H+ and e− as equation (1) from internal cysteine thiol group, and GSSG/2GSH couple is the most abundant redox couple that maintains the cell redox environment and homeostasis.60-61 As evidenced here, coincubation of bacterial cells with GSH antioxidant could remarkably attenuate the selective antimicrobial effect of nano-VO2 exposure against the tested Gram-positive bacteria. For S. aureus, coincubation with GSH could notably reduce the bacterial inactivation (Figure 7j) and intracellular ROS level (Figure 7l) induced by nano-VO2, indicating that oxidative stress was involved in their antimicrobial action. As for S. epidermidis, the antibacterial effect of nano-VO2 was entirely deactivated and the bacterial viability was significantly increased to the level of control (Figure 7k). At the same time, coincubation with GSH alleviated the intracellular ROS to the similar level (Figure 7m). To further demonstrate the AlamarBlue assay results, the CFU counting assay was also conducted on Gram-positive S. aureus and S. epidermidis with/without GSH co-incubation, and the representative photographs of recultivated bacteria colonies on SBA were given in\nFigure 10. H2O2 concentration dependent growth-inhibitory curves for the tested Gram-positive S. aureus (a1-a2), Gram-negative E. coli (b1-b2), Gram-positive S. epidermidis (c1-c2) and Gram-negative P. aeruginosa (d1-d2).\nFigure 8. According to the CFU counting results, before adding GSH, the antibacterial rates against S. aureus for VO-1, VO-2, VO-3 and VO4 were 6.5%, 66.7%, 69.8% and 70.2%, respectively. Similarly, the antibacterial ratios against S. epidermidis were 17.6%, 39.1%, 38.0% and 43.6%, respectively. By contrast, after GSH co-incubation, the CFU counting results had no significant difference between nano-VO2 and quartz control. Therefore, the CFU counting results were basically accordant with the AlamarBlue assay results, considering that these two assays had some differences in operating procedures (Please see details in experimental section). Figure 9 shows the live/dead fluorescence staining results of Gram-positive S. aureus and S. epidermidis after 24 h of co-incubation with GSH antioxidant. For the S. aureus (left panel), after adding GSH antioxidant, the green fluorescence on all samples showed significantly enhanced, indicating their exuberant vitality; meanwhile, GSH co-incubation, the CFU counting results had no significant difference between nanoVO2 and quartz control. Therefore, the CFU counting results were basically accordant with the AlamarBlue assay results, considering that these two assays had some differences in operating procedures (Please see details in experimental section). Visually, there was no significant difference between quartz and nano-VO2. Furthermore,\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n1 2\nM ay\n2 01\n6. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa nt\na B\nar ba\nra o\nn 14\n/0 5/\n20 16\n1 6:\n56 :1\n3.\nView Article Online DOI: 10.1039/C6NR02844F\nThis journal is © The Royal Society of Chemistry 2016 Nanoscale, 2016,XX, X-X | X\nFigure 11. Percentage of hemolysis of erythrocytes after 15 min, 30 min, 60 min, 4 h, and 12 h of incubation on samples VO-0, VO-1, VO-2, VO-3, and VO-4, respectively.\nthe corresponding red fluorescence showed remarkably reduced, consistent with the improved bacterial viability. Likewise, for S. epidermidis (right panel), the significantly enhanced green fluorescence and sharply reduced red fluorescence indicated their vigorous vitality, with no visual significant difference between quartz and nano-VO2. It showed that adding GSH antioxidant could effectively improve the bacterial viability of the Gram-positive S. aureus and S. epidermidis. These results indicated that oxidative stress was the major contributor to the selective antimicrobial effect of nano-VO2 against Gram-positive bacteria. At this stage, it can be inferred that, nano-VO2 exposure induced excess production of intracellular ROS, which exceeded the threshold level that Grampositive bacteria can self-regulate to maintain cellular redox homeostasis. The threshold can be reflected by the IC50 study of H2O2 discussed below. The elevated intracellular ROS level caused intracellular GSH depletion and disrupted cellular redox homeostasis, which finally induced oxidative stress and bacterial inactivation. So, it is emphasized that oxidative stress plays a major role in the selective antimicrobial activity of nano-VO2 against Gram-positive bacteria.\nTo give a complementary support, using H2O2 as ROS source, the H2O2 concentration dependent growth-inhibitory curves for the tested bacteria were plotted in Figure 10. And the IC50 values of H2O2 for S. aureus (Figure 10a1-a2) and E. coli (Figure 10b1-b2) were ~67.7 μM and ~223.6 μM, respectively. From this data, S. aureus seemed more sensitive to H2O2 than E. coli. Likewise, S. epidermidis with H2O2 IC50 value of ~156.5 μM (Figure 10c1-c2) also seemed more sensitive to H2O2 than P. aeruginosa with H2O2 IC50 value of ~250.2 mM (Figure 10d1-d2). This difference in sensitivity to ROS level might account for the selective antibacterial ability of nano-VO2 against the tested Gram-positive bacteria in this work.\nAccording to previous studies, the decavanadate [V10O28]6complex62-63 and vanadium(+5)-substituted polyoxometalate64-65 showed good antimicrobial activity. Wren et al. designed TiO2-V2O5 nanocomposite thin film and found that Ag doping could enhance the photocatalytical antibacterial ability.66 A recent work showed that the V2O5 nanoparticles possessed good antimicrobial property through causing ROS in bacteria.67\nTo summarize, we find the medicinal potential of VO2 material. As far as we know, this is the first report on the selective antibacterial property of VO2-based nanomaterials against Gram-positive bacteria, which holds great promise for environmental and biomedical applications, such as self-cleaning intelligent window, biofouling control, and treating bacterial infection-associated clinical diseases. 3.5. Hemolysis\nFigure 12. Proliferation viability of HIBEpiC after 1 d (a), 4 d (b) and 7 d (c) of culture on samples VO-0, VO-1, VO-2, VO-3, and VO-4; (d) Live/dead staining results of HIBEpiC after 4 d of culture on samples VO-0, VO-1, VO-2, VO-3, and VO-4. Note: *p < 0.05 vs VO-0; #p < 0.05 vs VO-0, VO-1, VO-2, and VO-3.\nThe influence of bare quartz (VO-0) and nano-VO2 (VO-1, VO-2,\nVO-3, and VO-4) on the isolated human RBC were assessed as a function of incubation time (15 min, 30 min, 60 min, 4 h, and 12 h). Figure 11 shows the results of percentage of hemolysis. As shown in Figure 11a, after 15 min of incubation, the quartz and nano-VO2 caused hemolysis were less than 2%. At the same time, there was no significant difference in the hemolysis between quartz and nano-VO2. Prolonging the incubation time to 30 min (Figure 11b) and 60 min (Figure 11c), the quartz and nano-VO2 caused hemolysis were no more than 3%, with no significant difference between them. Likewise, furthering the incubation time to 4 h (Figure 11d) and 12 h (Figure 11e), the quartz and nano-VO2 caused hemolysis were no more than 4%. More importantly, no statistical difference existed between the hemolysis of quartz and nano-VO2. The slight increase of hemolysis was due to the prolonged incubation time of the isolated RBC in PBS solution. During the experimental period, the nano-VO2 did not induce too severe hemolysis; in other words, they did not cause too much cytotoxicity against human erythrocytes."
    }, {
      "heading" : "3.6. Cytotoxicity",
      "text" : "It will make little sense in the case that an antibacterial material fails to support cell growth. Previous studies show that vanadium may cause hepatic toxicity.68-69 Here, human intrahepatic biliary epithelial cells (HIBEpiC) were used to evaluate the cytotoxicity of the nano-VO2 samples. The cell early proliferation at 1 d corresponds to the cell initial adhesion within 24 h.70 As shown in Figure 12a, at the early culture of 1 d, HIBEpiC can adhere on VO2 samples even better than on quartz glass. This is especially true for samples VO-2 and VO3. From Figure 1, it can be seen that a nanoparticle topography appeared on surface after depositing VO2, and this nanotopography became more and more distinct in a time dependent manner. Appropriate surface nanotopography can promote cell adhesion and spreading,70 which may account for the promoted HIBEpiC early proliferation. After culturing for 4 d, the HIBEpiC proliferation showed no significant difference among various groups (Figure 12b). Nevertheless, it is noticed that from Figure 12c, after 7 d of culture, the cell proliferation on nano-VO2 showed downward trend relative\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n1 2\nM ay\n2 01\n6. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa nt\na B\nar ba\nra o\nn 14\n/0 5/\n20 16\n1 6:\n56 :1\n3.\nView Article Online DOI: 10.1039/C6NR02844F\nX | Nanoscale, 2016,XX, X-X This journal is © The Royal Society of Chemistry 2016\nto that on quartz, especially a conspicuous gap emerging for VO-4. This indicated the potential cytotoxicity of nano-VO2 in a time and dose dependent manner. Live/dead cell staining was further used to visualize the cellular viability after 4 d of culture, as shown in Figure 12d (green for live cells, red for dead cells). By contrast with quartz glass, under CLSM, the total viable cell count had no significant decrease for VO2 samples visually, although some dead cells were observed on samples VO-2, VO-3 and VO-4, which was in accordance with the cell proliferation viability. Vanadium compounds in an appropriate dose can be used for cancer and diabetes treatment.25, 71 Clearing of vanadium uptake occurs ultimately through feces and urinary excretion; bones act as storage pool for vanadate and its biological detoxification through integration into the hydroxyapatite structure.55, 72-73 In fact, just as Paracelsus stated that “All substances are poisons; it is solely the dose that differentiates between a poison and a remedy” (“Alle Ding’ sind Gift, und nichts ohn’ Gift; allein die Dosis macht, daß ein Ding kein Gift ist”),74 there is so far no solid basis for categorizing vanadium compounds as toxic and harmful when administered in sensible amounts.75 So, balancing the antibacterial function and biocompatibility may expand new environmental and biomedical applications of VO2-based nanomaterials."
    }, {
      "heading" : "4. Conclusions",
      "text" : "In this work, pure VO2 from discrete nanoparticles to continuous films were successfully deposited on quartz glass by optimizing sputter parameters. The nano-VO2 could effectively reduce the bacterial viability of Gram-positive S. aureus and S. epidermidis, disrupt bacterial morphology and membrane integrity, induce oxidative stress and ultimately cause bacterial death. On the contrary, Gram-negative E. coli and P. aeruginosa did not exhibit the similar responses to nano-VO2, without significant toxic effects being observed. Therefore, to the best of our knowledge, a selective antibacterial property of VO2-based nanomaterials against Grampositive bacteria was demonstrated here for the first time. Based on experimental results, the plausible mechanism behind the antibacterial selectivity might result from the difference in sensitivity of Gram-positive bacteria and Gram-negative bacteria to intracellular ROS level. Excessive ROS production induced by nanoVO2 could cause oxidative stress and bacterial inactivation. Besides, the nano-VO2 did not cause significant cytotoxicity (hemolysis) against human erythrocytes within 12 h. Meanwhile, the potential cytotoxicity against HIBEpiC showed a time and dose dependent manner that might be controlled and balanced by elaborate design. The present finding in this work may be conducive to understanding the antibacterial actions of nano-VO2 and expanding the new applications of VO2-based nanomaterials in environmental and biomedical fields."
    }, {
      "heading" : "Acknowledgements",
      "text" : "The authors are grateful to the financial support by the hightech project of MOST (2014AA032802) and the Science and Technology Commission of Shanghai Municipality (STCSM, No.: 14DZ2261203).\nNotes and references\n1. Y. Gao, S. Wang, L. Kang, Z. Chen, J. Du, X. Liu, H. Luo and M. Kanehira, Energy & Environmental Science, 2012, 5, 8234-8237. 2. Q. Li, S. Mahendra, D. Y. Lyon, L. Brunet, M. V. Liga, D. Li and P. J.\nJ. Alvarez, Water Research, 2008, 42, 4591-4602. 3. L. B. Rice, Current Opinion in Microbiology, 2009, 12, 476-481. 4. M. L. Cohen, Nature, 2000, 406, 762-767. 5. H. S. Gold and R. C. Moellering, New England Journal of Medicine, 1996, 335, 1445-1453. 6. C. Subhankari Prasad, S. Sumanta Kumar, M. Santanu Kar, S. Susmita, B. Manjusri, R. Somenath and P. Panchanan, Nanotechnology, 2010, 21, 105103. 7. B. Périchon and P. Courvalin, Antimicrobial Agents and Chemotherapy, 2009, 53, 4580-4587. 8. H. W. Boucher, G. H. Talbot, J. S. Bradley, J. E. Edwards, D. Gilbert, L. B. Rice, M. Scheld, B. Spellberg and J. Bartlett, Clin. Infect. Dis., 2009, 48, 1-12. 9. M. J. Hajipour, K. M. Fromm, A. Akbar Ashkarran, D. Jimenez de Aberasturi, I. R. d. Larramendi, T. Rojo, V. Serpooshan, W. J. Parak and M. Mahmoudi, Trends in Biotechnology, 2012, 30, 499-511. 10. C. Kaweeteerawat, A. Ivask, R. Liu, H. Zhang, C. H. Chang, C. LowKam, H. Fischer, Z. Ji, S. Pokhrel, Y. Cohen, et al., Environmental Science & Technology, 2015, 49, 1105-1112. 11. A. J. Huh and Y. J. Kwon, Journal of Controlled Release, 2011, 156, 128-145. 12. A. K. Suresh, D. A. Pelletier and M. J. Doktycz, Nanoscale, 2013, 5, 463-474. 13. M. Elimelech and W. A. Phillip, Science, 2011, 333, 712-717. 14. M. P. Schultz, J. A. Bendick, E. R. Holm and W. M. Hertel, Biofouling, 2011, 27, 87-98. 15. L. F. Melo and T. R. Bott, Experimental Thermal and Fluid Science, 1997, 14, 375-381. 16. X. Shen, Y. Hu, G. Xu, W. Chen, K. Xu, Q. Ran, P. Ma, Y. Zhang, J. Li and K. Cai, ACS Applied Materials & Interfaces, 2014, 6, 16426-16440. 17. C. Gunawan, W. Y. Teoh, C. P. Marquis and R. Amal, ACS Nano, 2011, 5, 7214-7225. 18. A. Kubacka, M. S. Diez, D. Rojo, R. Bargiela, S. Ciordia, I. Zapico, J. P. Albar, C. Barbas, V. A. P. Martins dos Santos, M. Fernandez-Garcia, et al., Sci. Rep., 2014, 4, 4134. 19. J. M. Llobet and J. L. Domingo, Toxicology Letters, 1984, 23, 227- 231. 20. F. L. Assem and L. S. Levy, Journal of Toxicology and Environmental Health, Part B, 2009, 12, 289-306. 21. B. V. Venkataraman and S. Sudha, Asian Journal of Experimental Sciences, 2005, 19, 127-134. 22. S. Ghosh, R. Saha and B. Saha, Res Chem Intermed, 2015, 41, 4873-4897. 23. S. S. Soares, H. Martins, R. O. Duarte, J. J. G. Moura, J. Coucelo, C. Gutiérrez-Merino and M. Aureliano, Journal of Inorganic Biochemistry, 2007, 101, 80-88. 24. S. S. Soares, C. Gutiérrez-Merino and M. Aureliano, Aquatic Toxicology, 2007, 83, 1-9. 25. M. Aureliano, Dalton Transactions, 2009, 9093-9100. 26. D. Gambino, Coordination Chemistry Reviews, 2011, 255, 2193- 2203. 27. A. K. Haldar, S. Banerjee, K. Naskar, D. Kalita, N. S. Islam and S. Roy, Experimental Parasitology, 2009, 122, 145-154. 28. J. Benítez, L. Guggeri, I. Tomaz, G. Arrambide, M. Navarro, J. Costa Pessoa, B. Garat and D. Gambino, Journal of Inorganic Biochemistry, 2009, 103, 609-616. 29. S. Shigeta, S. Mori, T. Yamase, N. Yamamoto and N. Yamamoto, Biomedicine & Pharmacotherapy, 2006, 60, 211-219. 30. T. Yamase, E. Ishikawa, K. Fukaya, H. Nojiri, T. Taniguchi and T. Atake, Inorganic Chemistry, 2004, 43, 8150-8157. 31. P. I. da S. Maia, F. R. Pavan, C. Q. F. Leite, S. S. Lemos, G. F. de Sousa, A. A. Batista, O. R. Nascimento, J. Ellena, E. E. Castellano, E.\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n1 2\nM ay\n2 01\n6. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa nt\na B\nar ba\nra o\nn 14\n/0 5/\n20 16\n1 6:\n56 :1\n3.\nView Article Online DOI: 1 .1039/C6NR02844F\nThis journal is © The Royal Society of Chemistry 2016 Nanoscale, 2016,XX, X-X | X\nNiquet, et al., Polyhedron, 2009, 28, 398-406. 32. H. Zhou, X. Cao, M. Jiang, S. Bao and P. Jin, Laser & Photonics Reviews, 2014, 8, 617-625. 33. H. Zhou, J. Li, Y. Xin, X. Cao, S. Bao and P. Jin, Journal of Materials Chemistry C, 2015, 3, 5089-5097. 34. M. A. Esteban, T. Wang, B. Qin, J. Yang, D. Qin, J. Cai, W. Li, Z. Weng, J. Chen, S. Ni, et al., Cell Stem Cell, 2010, 6, 71-79. 35. H.-L. Su, C.-C. Chou, D.-J. Hung, S.-H. Lin, I. C. Pao, J.-H. Lin, F.-L. Huang, R.-X. Dong and J.-J. Lin, Biomaterials, 2009, 30, 5979-5987. 36. Y. Zhu, W. Li, Y. Zhang, J. Li, L. Liang, X. Zhang, N. Chen, Y. Sun, W. Chen, R. Tai, et al., Small, 2012, 8, 1771-1779. 37. A. M. Fuentes and C. F. Amábile-Cuevas, Microbiology, 1998, 144, 1731-1736. 38. S. P. Melegari, F. Perreault, S. Moukha, R. Popovic, E. E. Creppy and W. G. Matias, Chemosphere, 2012, 89, 38-43. 39. J. Wang, J. Li, S. Qian, G. Guo, Q. Wang, J. Tang, H. Shen, X. Liu, X. Zhang and P. K. Chu, ACS Applied Materials & Interfaces, 2016, 8, 11162–11178. 40. S. K. Jain, J. Rains and K. Jones, Free Radical Biology and Medicine, 2006, 41, 92-96. 41. G. A. Parks, Chemical Reviews, 1965, 65, 177-198. 42. L. Kang, Y. Gao and H. Luo, ACS Applied Materials & Interfaces, 2009, 1, 2211-2218. 43. N. D. Chasteen, Vanadium in biological systems. Springer: 1990. 44. S. Sabella, R. P. Carney, V. Brunetti, M. A. Malvindi, N. Al-Juffali, G. Vecchio, S. M. Janes, O. M. Bakr, R. Cingolani, F. Stellacci, et al., Nanoscale, 2014, 6, 7052-7061. 45. H. Zhou, J. Li, S. Bao, D. Wang, X. Liu and P. Jin, RSC Advances,"
    }, {
      "heading" : "2015, 5, 106315-106324.",
      "text" : "46. D. Rehder, Vanadium. Its Role for Humans. In Interrelations between Essential Metal Ions and Human Diseases, Sigel, A.; Sigel, H.and Sigel, R. K. O., Eds. Springer Netherlands: 2013; Vol. 13, pp 139- 169. 47. S. S. Soares, F. Henao, M. Aureliano and C. Gutiérrez-Merino, Chemical Research in Toxicology, 2008, 21, 607-618. 48. B. Mukherjee, B. Patra, S. Mahapatra, P. Banerjee, A. Tiwari and M. Chatterjee, Toxicology Letters, 2004, 150, 135-143. 49. M. Aureliano and R. M. C. Gândara, Journal of Inorganic Biochemistry, 2005, 99, 979-985. 50. M. Valko, H. Morris and M. T. D. Cronin, Current Medicinal Chemistry, 2005, 12, 1161-1208. 51. J. Li, G. Wang, H. Zhu, M. Zhang, X. Zheng, Z. Di, X. Liu and X. Wang, Sci. Rep., 2014, 4, 4359. 52. R. S. Ray, B. Rana, B. Swami, V. Venu and M. Chatterjee, ChemicoBiological Interactions, 2006, 163, 239-247. 53. J. R. Treberg, J. E. Stacey and W. R. Driedzic, Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 2012, 161, 323-330. 54. H. Michibata and T. Ueki, Advances in research on the accumulation, redox behavior, and function of vanadium in ascidians. In BioMolecular Concepts, 2010; Vol. 1, pp 97-107. 55. E. J. Baran, Chemistry & Biodiversity, 2008, 5, 1475-1484. 56. W. Legrum, Toxicology, 1986, 42, 281-289. 57. S. J. Stohs and D. Bagchi, Free Radical Biology and Medicine, 1995, 18, 321-336. 58. H. P. Monteiro, C. C. Winterbourn and A. Stern, Free Radical Research Communications, 1991, 12, 125-129. 59. R. C. Fahey, W. C. Brown, W. B. Adams and M. B. Worsham, Journal of Bacteriology, 1978, 133, 1126-1129. 60. C. C. Winterbourn and D. Metodiewa, Free Radical Biology and Medicine, 1999, 27, 322-328. 61. O. Carmel-Harel and G. Storz, Annual Review of Microbiology, 2000, 54, 439-461. 62. S. Chen, G. Wu, D. Long and Y. Liu, Carbohydrate Polymers, 2006, 64, 92-97. 63. S. Toumi, N. Ratel-Ramond and S. Akriche, Journal of Cluster Science, 2015, 26, 1821-1831. 64. T. Yamase, Journal of Materials Chemistry, 2005, 15, 4773-4782. 65. B. Hasenknopf, Front. Biosci, 2005, 10, 275-287. 66. A. W. Wren, B. M. Adams, D. Pradhan, M. R. Towler and N. P. Mellott, Materials Chemistry and Physics, 2014, 144, 538-546. 67. S. Raj, S. Kumar and K. Chatterjee, Materials Technology, 2016, 1- 12. 68. R. M. C. Gândara, S. S. Soares, H. Martins, C. Gutiérrez-Merino and M. Aureliano, Journal of Inorganic Biochemistry, 2005, 99, 1238- 1244. 69. Y. Zhao, L. Ye, H. Liu, Q. Xia, Y. Zhang, X. Yang and K. Wang, Journal of Inorganic Biochemistry, 2010, 104, 371-378. 70. J. Li, G. Wang, D. Wang, Q. Wu, X. Jiang and X. Liu, Journal of Colloid and Interface Science, 2014, 436, 160-170. 71. A. Bishayee, A. Waghray, M. A. Patel and M. Chatterjee, Cancer Letters, 2010, 294, 1-12. 72. G. Heinemann, B. Fichtl and W. Vogt, British Journal of Clinical Pharmacology, 2003, 55, 241-245. 73. K. H. Thompson, J. Lichter, C. LeBel, M. C. Scaife, J. H. McNeill and C. Orvig, Journal of Inorganic Biochemistry, 2009, 103, 554-558. 74. W. Chadwick and S. Maudsley, The Devil is in the Dose: Complexity of Receptor Systems and Responses. In Hormesis, Mattson, M. P.and Calabrese, E. J., Eds. Humana Press: 2010; pp 95- 108. 75. H. Michibata, Vanadium: biochemical and molecular biological approaches. Springer Science & Business Media: 2011.\nN an\nos ca\nle A\ncc ep\nte d\nM an\nus cr\nip t\nPu bl\nis he\nd on\n1 2\nM ay\n2 01\n6. D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf C\nal if\nor ni\na -\nSa nt\na B\nar ba\nra o\nn 14\n/0 5/\n20 16\n1 6:\n56 :1\n3.\nView Article Online DOI: 10.1039/C6NR0 844F"
    } ],
    "references" : [ {
      "title" : "and M",
      "author" : [ "Y. Gao", "S. Wang", "L. Kang", "Z. Chen", "J. Du", "X. Liu", "H. Lu" ],
      "venue" : "Kanehira, Energy & Environmental Science,",
      "citeRegEx" : "1",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "D",
      "author" : [ "Q. Li", "S. Mahendra", "D.Y. Lyon", "L. Brunet", "M.V. Liga" ],
      "venue" : "Li and P. J.  J. Alvarez, Water Research,",
      "citeRegEx" : "2",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "and R",
      "author" : [ "H.S. Gol" ],
      "venue" : "C. Moellering, New England Journal of Medicine,",
      "citeRegEx" : "5",
      "shortCiteRegEx" : null,
      "year" : 1996
    }, {
      "title" : "and P",
      "author" : [ "C. Subhankari Prasad", "S. Sumanta Kumar", "M. Santanu Kar", "S. Susmita", "B. Manjusri", "R. Somenat" ],
      "venue" : "Panchanan, Nanotechnology,",
      "citeRegEx" : "6",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "and P",
      "author" : [ "B. Péricho" ],
      "venue" : "Courvalin, Antimicrobial Agents and Chemotherapy,",
      "citeRegEx" : "7",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Clin",
      "author" : [ "H.W. Boucher", "G.H. Talbot", "J.S. Bradley", "J.E. Edwards", "D. Gilbert", "L.B. Rice", "M. Scheld", "B. Spellberg", "J. Bartlett" ],
      "venue" : "Infect. Dis.,",
      "citeRegEx" : "8",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "de Aberasturi, I",
      "author" : [ "M.J. Hajipour", "K.M. Fromm", "A. Akbar Ashkarran", "D. Jimene" ],
      "venue" : "R. d. Larramendi, T. Rojo, V. Serpooshan, W. J. Parak and M. Mahmoudi, Trends in Biotechnology,",
      "citeRegEx" : "9",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Y",
      "author" : [ "C. Kaweeteerawat", "A. Ivask", "R. Liu", "H. Zhang", "C.H. Chang", "C. LowKam", "H. Fischer", "Z. Ji", "S. Pokhrel" ],
      "venue" : "Cohen, et al., Environmental Science & Technology,",
      "citeRegEx" : "10",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and Y",
      "author" : [ "A.J. Hu" ],
      "venue" : "J. Kwon, Journal of Controlled Release,",
      "citeRegEx" : "11",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "and M",
      "author" : [ "A.K. Suresh", "D.A. Pelletie" ],
      "venue" : "J. Doktycz, Nanoscale,",
      "citeRegEx" : "12",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and W",
      "author" : [ "M. Elimelec" ],
      "venue" : "A. Phillip, Science,",
      "citeRegEx" : "13",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "and W",
      "author" : [ "M.P. Schultz", "J.A. Bendick", "E.R. Hol" ],
      "venue" : "M. Hertel, Biofouling,",
      "citeRegEx" : "14",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "and T",
      "author" : [ "L.F. Mel" ],
      "venue" : "R. Bott, Experimental Thermal and Fluid Science,",
      "citeRegEx" : "15",
      "shortCiteRegEx" : null,
      "year" : 1997
    }, {
      "title" : "J",
      "author" : [ "X. Shen", "Y. Hu", "G. Xu", "W. Chen", "K. Xu", "Q. Ran", "P. Ma", "Y. Zhang" ],
      "venue" : "Li and K. Cai, ACS Applied Materials & Interfaces,",
      "citeRegEx" : "16",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and R",
      "author" : [ "C. Gunawan", "W.Y. Teoh", "C.P. Marqui" ],
      "venue" : "Amal, ACS Nano,",
      "citeRegEx" : "17",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "dos Santos, M",
      "author" : [ "A. Kubacka", "M.S. Diez", "D. Rojo", "R. Bargiela", "S. Ciordia", "I. Zapico", "J.P. Albar", "C. Barbas", "V.A.P. Martin" ],
      "venue" : "Fernandez-Garcia, et al., Sci. Rep.,",
      "citeRegEx" : "18",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and J",
      "author" : [ "J.M. Llobe" ],
      "venue" : "L. Domingo, Toxicology Letters,",
      "citeRegEx" : "19",
      "shortCiteRegEx" : null,
      "year" : 1984
    }, {
      "title" : "and L",
      "author" : [ "F.L. Asse" ],
      "venue" : "S. Levy, Journal of Toxicology and Environmental Health, Part B,",
      "citeRegEx" : "20",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "and S",
      "author" : [ "B.V. Venkatarama" ],
      "venue" : "Sudha, Asian Journal of Experimental Sciences,",
      "citeRegEx" : "21",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "and B",
      "author" : [ "S. Ghosh", "R. Sah" ],
      "venue" : "Saha, Res Chem Intermed,",
      "citeRegEx" : "22",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and M",
      "author" : [ "S.S. Soares", "H. Martins", "R.O. Duarte", "J.J.G. Moura", "J. Coucelo", "C. Gutiérrez-Merin" ],
      "venue" : "Aureliano, Journal of Inorganic Biochemistry,",
      "citeRegEx" : "23",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "and M",
      "author" : [ "S.S. Soares", "C. Gutiérrez-Merin" ],
      "venue" : "Aureliano, Aquatic Toxicology,",
      "citeRegEx" : "24",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "and S",
      "author" : [ "A.K. Haldar", "S. Banerjee", "K. Naskar", "D. Kalita", "N.S. Isla" ],
      "venue" : "Roy, Experimental Parasitology,",
      "citeRegEx" : "27",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "and D",
      "author" : [ "J. Benítez", "L. Guggeri", "I. Tomaz", "G. Arrambide", "M. Navarro", "J. Costa Pessoa", "B. Gara" ],
      "venue" : "Gambino, Journal of Inorganic Biochemistry,",
      "citeRegEx" : "28",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "and N",
      "author" : [ "S. Shigeta", "S. Mori", "T. Yamase", "N. Yamamot" ],
      "venue" : "Yamamoto, Biomedicine & Pharmacotherapy,",
      "citeRegEx" : "29",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "and T",
      "author" : [ "T. Yamase", "E. Ishikawa", "K. Fukaya", "H. Nojiri", "T. Taniguch" ],
      "venue" : "Atake, Inorganic Chemistry,",
      "citeRegEx" : "30",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "Nanoscale N  an  os  ca  le  A  cc  ep  te  d  M  an  us  cr  ip t Pu  bl  is  he  d  on  1  2  M  ay  2  01 6.  D  ow  nl  oa  de  d  by  U  ni  ve  rs  ity  o  f  C  al  if  or  ni  a   Sa  nt  a  B  ar  ba  ra  o  n",
      "author" : [ "P.I. da S. Maia", "F.R. Pavan", "C.Q.F. Leite", "S.S. Lemos", "G.F. de Sousa", "A.A. Batista", "O.R. Nascimento", "J. Ellena", "E.E.E. Castellano" ],
      "venue" : null,
      "citeRegEx" : "31",
      "shortCiteRegEx" : "31",
      "year" : 2009
    }, {
      "title" : "and P",
      "author" : [ "H. Zhou", "X. Cao", "M. Jiang", "S. Ba" ],
      "venue" : "Jin, Laser & Photonics Reviews,",
      "citeRegEx" : "32",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and P",
      "author" : [ "H. Zhou", "J. Li", "Y. Xin", "X. Cao", "S. Ba" ],
      "venue" : "Jin, Journal of Materials Chemistry C,",
      "citeRegEx" : "33",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "S",
      "author" : [ "M.A. Esteban", "T. Wang", "B. Qin", "J. Yang", "D. Qin", "J. Cai", "W. Li", "Z. Weng", "J. Chen" ],
      "venue" : "Ni, et al., Cell Stem Cell,",
      "citeRegEx" : "34",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "I",
      "author" : [ "H.-L. Su", "C.-C. Chou", "D.-J. Hung", "S.-H. Lin" ],
      "venue" : "C. Pao, J.-H. Lin, F.-L. Huang, R.-X. Dong and J.-J. Lin, Biomaterials,",
      "citeRegEx" : "35",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "R",
      "author" : [ "Y. Zhu", "W. Li", "Y. Zhang", "J. Li", "L. Liang", "X. Zhang", "N. Chen", "Y. Sun", "W. Chen" ],
      "venue" : "Tai, et al., Small,",
      "citeRegEx" : "36",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "and C",
      "author" : [ "A.M. Fuente" ],
      "venue" : "F. Amábile-Cuevas, Microbiology,",
      "citeRegEx" : "37",
      "shortCiteRegEx" : null,
      "year" : 1998
    }, {
      "title" : "and W",
      "author" : [ "S.P. Melegari", "F. Perreault", "S. Moukha", "R. Popovic", "E.E. Crepp" ],
      "venue" : "G. Matias, Chemosphere,",
      "citeRegEx" : "38",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "and P",
      "author" : [ "J. Wang", "J. Li", "S. Qian", "G. Guo", "Q. Wang", "J. Tang", "H. Shen", "X. Liu", "X. Zhan" ],
      "venue" : "K. Chu, ACS Applied Materials & Interfaces,",
      "citeRegEx" : "39",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and K",
      "author" : [ "S.K. Jain", "J. Rain" ],
      "venue" : "Jones, Free Radical Biology and Medicine,",
      "citeRegEx" : "40",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "and H",
      "author" : [ "L. Kang", "Y. Ga" ],
      "venue" : "Luo, ACS Applied Materials & Interfaces,",
      "citeRegEx" : "42",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Vanadium in biological systems",
      "author" : [ "N.D. Chasteen" ],
      "venue" : "Springer:",
      "citeRegEx" : "43",
      "shortCiteRegEx" : null,
      "year" : 1990
    }, {
      "title" : "F",
      "author" : [ "S. Sabella", "R.P. Carney", "V. Brunetti", "M.A. Malvindi", "N. Al-Juffali", "G. Vecchio", "S.M. Janes", "O.M. Bakr", "R. Cingolani" ],
      "venue" : "Stellacci, et al., Nanoscale,",
      "citeRegEx" : "44",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and P",
      "author" : [ "H. Zhou", "J. Li", "S. Bao", "D. Wang", "X. Li" ],
      "venue" : "Jin, RSC Advances,",
      "citeRegEx" : "45",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Vanadium",
      "author" : [ "D. Rehder" ],
      "venue" : "Its Role for Humans. In Interrelations between Essential Metal Ions and Human Diseases, Sigel, A.; Sigel, H.and Sigel, R. K. O., Eds. Springer Netherlands:",
      "citeRegEx" : "46",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and C",
      "author" : [ "S.S. Soares", "F. Henao", "M. Aurelian" ],
      "venue" : "Gutiérrez-Merino, Chemical Research in Toxicology,",
      "citeRegEx" : "47",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "and M",
      "author" : [ "B. Mukherjee", "B. Patra", "S. Mahapatra", "P. Banerjee", "A. Tiwar" ],
      "venue" : "Chatterjee, Toxicology Letters,",
      "citeRegEx" : "48",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "and R",
      "author" : [ "M. Aurelian" ],
      "venue" : "M. C. Gândara, Journal of Inorganic Biochemistry,",
      "citeRegEx" : "49",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "and M",
      "author" : [ "M. Valko", "H. Morri" ],
      "venue" : "T. D. Cronin, Current Medicinal Chemistry,",
      "citeRegEx" : "50",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "Sci",
      "author" : [ "J. Li", "G. Wang", "H. Zhu", "M. Zhang", "X. Zheng", "Z. Di", "X. Liu", "X. Wang" ],
      "venue" : "Rep.,",
      "citeRegEx" : "51",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and M",
      "author" : [ "R.S. Ray", "B. Rana", "B. Swami", "V. Ven" ],
      "venue" : "Chatterjee, ChemicoBiological Interactions,",
      "citeRegEx" : "52",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "and W",
      "author" : [ "J.R. Treberg", "J.E. Stace" ],
      "venue" : "R. Driedzic, Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology,",
      "citeRegEx" : "53",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Advances in research on the accumulation, redox behavior, and function of vanadium in ascidians",
      "author" : [ "H. Michibata", "T. Ueki" ],
      "venue" : "In BioMolecular Concepts,",
      "citeRegEx" : "54",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "and D",
      "author" : [ "S.J. Stoh" ],
      "venue" : "Bagchi, Free Radical Biology and Medicine,",
      "citeRegEx" : "57",
      "shortCiteRegEx" : null,
      "year" : 1995
    }, {
      "title" : "and A",
      "author" : [ "H.P. Monteiro", "C.C. Winterbour" ],
      "venue" : "Stern, Free Radical Research Communications,",
      "citeRegEx" : "58",
      "shortCiteRegEx" : null,
      "year" : 1991
    }, {
      "title" : "and M",
      "author" : [ "R.C. Fahey", "W.C. Brown", "W.B. Adam" ],
      "venue" : "B. Worsham, Journal of Bacteriology,",
      "citeRegEx" : "59",
      "shortCiteRegEx" : null,
      "year" : 1978
    }, {
      "title" : "and D",
      "author" : [ "C.C. Winterbour" ],
      "venue" : "Metodiewa, Free Radical Biology and Medicine,",
      "citeRegEx" : "60",
      "shortCiteRegEx" : null,
      "year" : 1999
    }, {
      "title" : "and G",
      "author" : [ "O. Carmel-Hare" ],
      "venue" : "Storz, Annual Review of Microbiology, ",
      "citeRegEx" : "61",
      "shortCiteRegEx" : null,
      "year" : 2000
    }, {
      "title" : "and Y",
      "author" : [ "S. Chen", "G. Wu", "D. Lon" ],
      "venue" : "Liu, Carbohydrate Polymers,",
      "citeRegEx" : "62",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "and S",
      "author" : [ "S. Toumi", "N. Ratel-Ramon" ],
      "venue" : "Akriche, Journal of Cluster Science,",
      "citeRegEx" : "63",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Front",
      "author" : [ "B. Hasenknopf" ],
      "venue" : "Biosci,",
      "citeRegEx" : "65",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "and N",
      "author" : [ "A.W. Wren", "B.M. Adams", "D. Pradhan", "M.R. Towle" ],
      "venue" : "P. Mellott, Materials Chemistry and Physics,",
      "citeRegEx" : "66",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and K",
      "author" : [ "S. Raj", "S. Kuma" ],
      "venue" : "Chatterjee, Materials Technology,",
      "citeRegEx" : "67",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and M",
      "author" : [ "R.M.C. Gândara", "S.S. Soares", "H. Martins", "C. Gutiérrez-Merin" ],
      "venue" : "Aureliano, Journal of Inorganic Biochemistry,",
      "citeRegEx" : "68",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "and K",
      "author" : [ "Y. Zhao", "L. Ye", "H. Liu", "Q. Xia", "Y. Zhang", "X. Yan" ],
      "venue" : "Wang, Journal of Inorganic Biochemistry,",
      "citeRegEx" : "69",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "and X",
      "author" : [ "J. Li", "G. Wang", "D. Wang", "Q. Wu", "X. Jian" ],
      "venue" : "Liu, Journal of Colloid and Interface Science,",
      "citeRegEx" : "70",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and M",
      "author" : [ "A. Bishayee", "A. Waghray", "M.A. Pate" ],
      "venue" : "Chatterjee, Cancer Letters,",
      "citeRegEx" : "71",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "and W",
      "author" : [ "G. Heinemann", "B. Ficht" ],
      "venue" : "Vogt, British Journal of Clinical Pharmacology,",
      "citeRegEx" : "72",
      "shortCiteRegEx" : null,
      "year" : 2003
    }, {
      "title" : "and C",
      "author" : [ "K.H. Thompson", "J. Lichter", "C. LeBel", "M.C. Scaife", "J.H. McNeil" ],
      "venue" : "Orvig, Journal of Inorganic Biochemistry,",
      "citeRegEx" : "73",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "The Devil is in the Dose: Complexity of Receptor Systems and Responses",
      "author" : [ "W. Chadwick", "S. Maudsley" ],
      "venue" : "In Hormesis, Mattson, M. P.and Calabrese, E. J., Eds. Humana Press:",
      "citeRegEx" : "74",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Vanadium: biochemical and molecular biological approaches",
      "author" : [ "H. Michibata" ],
      "venue" : "Springer Science & Business Media:",
      "citeRegEx" : "75",
      "shortCiteRegEx" : null,
      "year" : 2011
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "25, 47, 52 In this case, the bioreduction of H2VO4 to VO2+ begins with the redox couple as equation (1): 2GSH↔GSSG + 2H+ + 2e(1)",
      "startOffset" : 100,
      "endOffset" : 103
    }, {
      "referenceID" : 0,
      "context" : "25, 47, 52 In this case, the bioreduction of H2VO4 to VO2+ begins with the redox couple as equation (1): 2GSH↔GSSG + 2H+ + 2e(1)",
      "startOffset" : 125,
      "endOffset" : 128
    }, {
      "referenceID" : 1,
      "context" : "53-54 Secondly, the bioreduction reaction occurs as equation (2):47, 55 H2VO4 + 4H+ + e- ↔ VO2+ + 3H2O (2) In fact, an in vitro study demonstrated that H2VO4 was completely reduced to VO2+ by GSH.",
      "startOffset" : 61,
      "endOffset" : 64
    }, {
      "referenceID" : 1,
      "context" : "53-54 Secondly, the bioreduction reaction occurs as equation (2):47, 55 H2VO4 + 4H+ + e- ↔ VO2+ + 3H2O (2) In fact, an in vitro study demonstrated that H2VO4 was completely reduced to VO2+ by GSH.",
      "startOffset" : 103,
      "endOffset" : 106
    }, {
      "referenceID" : 0,
      "context" : "59 GSH scavenges ROS by donating H+ and e− as equation (1) from internal cysteine thiol group, and GSSG/2GSH couple is the most abundant redox couple that maintains the cell redox environment and homeostasis.",
      "startOffset" : 55,
      "endOffset" : 58
    } ],
    "year" : 2016,
    "abstractText" : "Please note that technical editing may introduce minor changes to the text and/or graphics, which may alter content. The journal’s standard Terms & Conditions and the Ethical guidelines still apply. In no event shall the Royal Society of Chemistry be held responsible for any errors or omissions in this Accepted Manuscript or any consequences arising from the use of any information it contains. Accepted Manuscript Nanoscale",
    "creator" : "Aspose Ltd."
  }
}